The plasticity of regulatory T cell function

Journal of Immunology

Volumn 187, Issue 10, 2011, Pages 4987-4997

  Pillai, Meenu R ^a   Collison, Lauren W ^a,d   Wang, Xiaohua ^a,e   Finkelstein, David ^a   Rehg, Jerold E ^a   Boyd, Kelli ^a,f   Szymczak Workman, Andrea L ^a   Doggett, Teresa ^b   Griffith, Thomas S ^c   Ferguson, Thomas A ^b   Vignali, Dario A A ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d Opexa Therapeutics   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN E; CD45RB ANTIGEN; CYCLIC AMP; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 35; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL FUNCTION; COLITIS; CONTROLLED STUDY; CYTOKINE RELEASE; ENTERITIS; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HOMEOSTASIS; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PLASTICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; UPREGULATION; WEIGHT GAIN; WEIGHT REDUCTION;

ANIMALS; CATHEPSIN E; CELLS, CULTURED; COCULTURE TECHNIQUES; DOWN-REGULATION; HEK293 CELLS; HUMANS; INTERLEUKIN-10; INTERLEUKINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; T-LYMPHOCYTES, REGULATORY; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 81455131850     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102173     Document Type: Article

References (51)

1. Sakaguchi, S., N. Sakaguchi, J. Shimizu, S. Yamazaki, T. Sakihama, M. Itoh, Y. Kuniyasu, T. Nomura, M. Toda, and T. Takahashi. 2001. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 182: 18-32. (Pubitemid 33070205)
2. Vignali, D. A., L. W. Collison, and C. J. Workman. 2008. How regulatory T cells work. Nat. Rev. Immunol. 8: 523-532.
3. Tang, Q., and J. A. Bluestone. 2008. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat. Immunol. 9: 239-244. (Pubitemid 351267321)
4. Thornton, A. M., and E. M. Shevach. 1998. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188: 287-296. (Pubitemid 28357757)
5. Park, Y., S. J. Oh, and D. H. Chung. 2009. CD4(+)CD25(+) regulatory T cells attenuate hypersensitivity pneumonitis by suppressing IFN-gamma production by CD4(+) and CD8(+) T cells. J. Leukoc. Biol. 86: 1427-1437.
6. Yang, Z. Z., A. J. Novak, M. J. Stenson, T. E. Witzig, and S. M. Ansell. 2006. Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma. Blood 107: 3639-3646.
7. Tadokoro, C. E., G. Shakhar, S. Shen, Y. Ding, A. C. Lino, A. Maraver, J. J. Lafaille, and M. L. Dustin. 2006. Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo. J. Exp. Med. 203: 505-511.
8. Zaiss, M. M., R. Axmann, J. Zwerina, K. Polzer, E. Gückel, A. Skapenko, H. Schulze-Koops, N. Horwood, A. Cope, and G. Schett. 2007. Treg cells suppress osteoclast formation: a new link between the immune system and bone. Arthritis Rheum. 56: 4104-4112. (Pubitemid 350262338)
9. Vignali, D. 2008. How many mechanisms do regulatory T cells need? Eur. J. Immunol. 38: 908-911.
10. Zheng, Y., A. Chaudhry, A. Kas, P. deRoos, J. M. Kim, T. T. Chu, L. Corcoran, P. Treuting, U. Klein, and A. Y. Rudensky. 2009. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 458: 351-356.
11. Koch, M. A., G. Tucker-Heard, N. R. Perdue, J. R. Killebrew, K. B. Urdahl, and D. J. Campbell. 2009. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 10: 595-602.
12. Chaudhry, A., D. Rudra, P. Treuting, R. M. Samstein, Y. Liang, A. Kas, and A. Y. Rudensky. 2009. CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 326: 986-991.
13. Williams, L. M., and A. Y. Rudensky. 2007. Maintenance of the Foxp3- dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat. Immunol. 8: 277-284. (Pubitemid 46745377)
14. Mottet, C., H. H. Uhlig, and F. Powrie. 2003. Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J. Immunol. 170: 3939-3943. (Pubitemid 36428153)
15. Marie, J. C., J. J. Letterio, M. Gavin, and A. Y. Rudensky. 2005. TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J. Exp. Med. 201: 1061-1067. (Pubitemid 40524674)
16. Collison, L. W., C. J. Workman, T. T. Kuo, K. Boyd, Y. Wang, K. M. Vignali, R. Cross, D. Sehy, R. S. Blumberg, and D. A. Vignali. 2007. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450: 566-569. (Pubitemid 350190247)
17. Collison, L. W., M. R. Pillai, V. Chaturvedi, and D. A. Vignali. 2009. Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35- and IL- 10-dependent manner. J. Immunol. 182: 6121-6128.
18. Rubtsov, Y. P., J. P. Rasmussen, E. Y. Chi, J. Fontenot, L. Castelli, X. Ye, P. Treuting, L. Siewe, A. Roers, W. R. Henderson, Jr., et al. 2008. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28: 546-558.
19. Fontenot, J. D., M. A. Gavin, and A. Y. Rudensky. 2003. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4: 330-336. (Pubitemid 36432314)
20. Brunkow, M. E., E. W. Jeffery, K. A. Hjerrild, B. Paeper, L. B. Clark, S. A. Yasayko, J. E. Wilkinson, D. Galas, S. F. Ziegler, and F. Ramsdell. 2001. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27: 68-73. (Pubitemid 32044521)
21. Tulone, C., J. Tsang, Z. Prokopowicz, N. Grosvenor, and B. Chain. 2007. Natural cathepsin E deficiency in the immune system of C57BL/6J mice. Immunogenetics 59: 927-935. (Pubitemid 50002834)
22. Collison, L. W., and D. A. Vignali. 2011. In vitro Treg suppression assays. Methods Mol. Biol. 707: 21-37.
23. Workman, C. J., L. W. Collison, M. Bettini, M. R. Pillai, J. E. Rehg, and D. A. Vignali. 2011. In vivo Treg suppression assays. Methods Mol. Biol. 707: 119-156.
24. Rocke, D. M., and B. Durbin. 2003. Approximate variance-stabilizing transformations for gene-expression microarray data. Bioinformatics 19: 966-972. (Pubitemid 36675817)
25. DiPaolo, R. J., C. Brinster, T. S. Davidson, J. Andersson, D. Glass, and E. M. Shevach. 2007. Autoantigen-specific TGFbeta-induced Foxp3+ regulatory T cells prevent autoimmunity by inhibiting dendritic cells from activating autoreactive T cells. J. Immunol. 179: 4685-4693.
26. Huter, E. N., G. A. Punkosdy, D. D. Glass, L. I. Cheng, J. M. Ward, and E. M. Shevach. 2008. TGF-beta-induced Foxp3+ regulatory T cells rescue scurfy mice. Eur. J. Immunol. 38: 1814-1821.
27. Rocha, B., N. Dautigny, and P. Pereira. 1989. Peripheral T lymphocytes: expansion potential and homeostatic regulation of pool sizes and CD4/CD8 ratios in vivo. Eur. J. Immunol. 19: 905-911. (Pubitemid 19165451)
28. Workman, C. J., and D. A. Vignali. 2005. Negative regulation of T cell homeostasis by lymphocyte activation gene-3 (CD223). J. Immunol. 174: 688-695. (Pubitemid 40094261)
29. Bell, E. B., S. M. Sparshott, M. T. Drayson, and W. L. Ford. 1987. The stable and permanent expansion of functional T lymphocytes in athymic nude rats after a single injection of mature T cells. J. Immunol. 139: 1379-1384. (Pubitemid 17141544)
30. Asseman, C., S. Mauze, M. W. Leach, R. L. Coffman, and F. Powrie. 1999. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190: 995-1004.
31. Izcue, A., J. L. Coombes, and F. Powrie. 2006. Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol. Rev. 212: 256-271. (Pubitemid 44116713)
32. Gorelik, L., and R. A. Flavell. 2000. Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12: 171-181. (Pubitemid 30398631)
33. Robinson, M. S., and J. S. Bonifacino. 2001. Adaptor-related proteins. Curr. Opin. Cell Biol. 13: 444-453. (Pubitemid 32709768)
34. Zaidi, N., and H. Kalbacher. 2008. Cathepsin E: a mini review. Biochem. Biophys. Res. Commun. 367: 517-522.
35. Yasukochi, A., T. Kawakubo, S. Nakamura, and K. Yamamoto. 2010. Cathepsin E enhances anticancer activity of doxorubicin on human prostate cancer cells showing resistance to TRAIL-mediated apoptosis. Biol. Chem. 391: 947-958.
36. Kawakubo, T., K. Okamoto, J. Iwata, M. Shin, Y. Okamoto, A. Yasukochi, K. I. Nakayama, T. Kadowaki, T. Tsukuba, and K. Yamamoto. 2007. Cathepsin E prevents tumor growth and metastasis by catalyzing the proteolytic release of soluble TRAIL from tumor cell surface. Cancer Res. 67: 10869-10878. (Pubitemid 350145916)
37. Wang, S., and W. S. El-Deiry. 2003. TRAIL and apoptosis induction by TNF-family death receptors. Oncogene 22: 8628-8633. (Pubitemid 38019198)
38. Hoffmann, O., F. Zipp, and J. R. Weber. 2009. Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in central nervous system inflammation. J. Mol. Med. 87: 753-763.
39. Kimberley, F. C., and G. R. Screaton. 2004. Following a TRAIL: update on a ligand and its five receptors. Cell Res. 14: 359-372. (Pubitemid 43231798)
40. Ren, X., F. Ye, Z. Jiang, Y. Chu, S. Xiong, and Y. Wang. 2007. Involvement of cellular death in TRAIL/DR5-dependent suppression induced by CD4(+)CD25(+) regulatory T cells. Cell Death Differ. 14: 2076-2084. (Pubitemid 350131157)
41. Griffith, T. S., E. L. Brincks, P. Gurung, T. A. Kucaba, and T. A. Ferguson. 2011. Systemic immunological tolerance to ocular antigens is mediated by TRAIL-expressing CD8+ T cells. J. Immunol. 186: 791-798.
42. Gregoli, P. A., and M. C. Bondurant. 1999. Function of caspases in regulating apoptosis caused by erythropoietin deprivation in erythroid progenitors. J. Cell. Physiol. 178: 133-143. (Pubitemid 29034856)
43. Bossen, C., K. Ingold, A. Tardivel, J. L. Bodmer, O. Gaide, S. Hertig, C. Ambrose, J. Tschopp, and P. Schneider. 2006. Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human. J. Biol. Chem. 281: 13964-13971. (Pubitemid 43848322)
44. Kayagaki, N., N. Yamaguchi, M. Nakayama, H. Eto, K. Okumura, and H. Yagita. 1999. Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: a novel mechanism for the antitumor effects of type I IFNs. J. Exp. Med. 189: 1451-1460. (Pubitemid 29227531)
45. Zhang, X. R., L. Y. Zhang, S. Devadas, L. Li, A. D. Keegan, and Y. F. Shi. 2003. Reciprocal expression of TRAIL and CD95L in Th1 and Th2 cells: role of apoptosis in T helper subset differentiation. Cell Death Differ. 10: 203-210. (Pubitemid 36553462)
46. Wohlfert, E., and Y. Belkaid. 2010. Plasticity of T reg at infected sites. Mucosal Immunol. 3: 213-215.
47. Backus, G. S., R. Howden, J. Fostel, A. K. Bauer, H. Y. Cho, J. Marzec, D. B. Peden, and S. R. Kleeberger. 2010. Protective role of interleukin-10 in ozone-induced pulmonary inflammation. Environ. Health Perspect. 118: 1721-1727.
48. Monleón, I., M. J. Martínez-Lorenzo, L. Monteagudo, P. Lasierra, M. Taulés, M. Iturralde, A. Piñeiro, L. Larrad, M. A. Alava, J. Naval, and A. Anel. 2001. Differential secretion of Fas ligand- or APO2 ligand/TNF-related apoptosis-inducing ligand-carrying microvesicles during activation-induced death of human T cells. J. Immunol. 167: 6736-6744. (Pubitemid 33144163)
49. Mariani, S. M., and P. H. Krammer. 1998. Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage. Eur. J. Immunol. 28: 973-982. (Pubitemid 28116210)
50. Gorham, J. D., M. L. Güler, R. G. Steen, A. J. Mackey, M. J. Daly, K. Frederick, W. F. Dietrich, and K. M. Murphy. 1996. Genetic mapping of a murine locus controlling development of T helper 1/T helper 2 type responses. Proc. Natl. Acad. Sci. USA 93: 12467-12472.
51. Okamoto, M., M. Van Stry, L. Chung, M. Koyanagi, X. Sun, Y. Suzuki, O. Ohara, H. Kitamura, A. Hijikata, M. Kubo, and M. Bix. 2009. Mina, an Il4 repressor, controls T helper type 2 bias. Nat. Immunol. 10: 872-879.